Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs ▲ | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| MorphoSys AG | 7 | 0 | 0 | 0 | 67,75 € | 65,00 € | -4,06 % |
| QIAGEN NV | 8 | 0 | 0 | 0 | 40,47 € | 47,44 € | 17,22 % |
| Perrigo Co. plc | 3 | 0 | 0 | 0 | 24,97 € | 35,99 € | 44,11 % |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | 1,29 € | 3,70 € | 186,60 % |
| Repligen Corp. | 13 | 0 | 0 | 0 | 138,05 € | 184,76 € | 33,84 % |
| Neurocrine Bioscience | 31 | 0 | 4 | 0 | 124,00 € | 140,60 € | 13,39 % |
| United Therapeutics | 20 | 0 | 2 | 0 | 251,10 € | 287,40 € | 14,46 % |
| Exelixis Inc. | 18 | 0 | 0 | 0 | 20,12 € | 26,01 € | 29,26 % |
| Arrowhead Pharmaceuticals Inc. | 16 | 2 | 4 | 0 | 23,25 € | 54,74 € | 135,42 % |
| Alnylam Pharmace. | 36 | 0 | 1 | 0 | 137,80 € | 236,30 € | 71,48 % |
| Halozyme Therapeutics Inc. | 16 | 0 | 3 | 0 | 40,70 € | 47,07 € | 15,66 % |
| Amicus Therapeutics Inc. | 7 | 0 | 4 | 0 | 9,25 € | 17,64 € | 90,68 % |
| Icon plc | 21 | 0 | 3 | 0 | 292,30 € | 323,37 € | 10,63 % |
| Horizon Pharma plc | 4 | 0 | 0 | 0 | 110,40 € | - | - |
| PTC Therapeutics Inc. | 15 | 8 | 2 | 3 | 33,60 € | 41,51 € | 23,55 % |
| Agios Pharmaceuticals Inc. | 7 | 0 | 2 | 0 | 43,60 € | 48,75 € | 11,81 % |
| Xencor Inc. | 10 | 1 | 1 | 0 | 21,60 € | 32,58 € | 50,83 % |
| Ultragenyx Pharmaceutical Inc. | 21 | 1 | 4 | 0 | 37,60 € | 84,74 € | 125,38 % |
| Uniqure B.V. | 1 | 0 | 1 | 0 | 4,89 € | - | - |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | 124,00 € | 150,00 € | 20,97 % |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | 93,64 € | - | - |
| Novocure Ltd | 1 | 1 | 0 | 0 | 20,99 € | - | - |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | 17,30 € | 45,10 € | 160,66 % |